Worth reading
49Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
14.8
Year-on-year change in revenue (%)Wording
Conditional
How definitive the wording is.Items stated in the management plan
Annual updateNet Sales+14.8%
基準 8,278Target9,500million
Operating profit+0.0%
基準 2,026Target2,027million
Net income for the current fiscal year+0.0%
基準 2,026Target2,027million
Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
What happened to the previous planMedium-Term Management Target (¥1 billion in operating profit) → Achieved ahead of schedule in the fiscal year ended March 2023+202,200.0%Calculated from the two disclosed figures
Statements about the use of capital
Payout ratio / DOE policyNumerical targets for the payout ratio and DOE are not disclosed. The basic policy is to continuously increase dividends per share. The dividend forecast for the fiscal year ending March 2027 is ¥36. The period covered is as long as medium- to long-term earnings growth and EPS growth are expected.The payout ratio is the proportion of profit paid out as dividends, while DOE is the ratio of dividends to net assets.
Key initiatives
01Strengthen the operating structure through the use of AI
02Strengthen sales by building a sales organization
03Expand customer categories beyond beauty
04Develop services integrated with e-commerce
05Increase users and expand the customer base by enhancing real-world experiences and the community
06Achieve continued growth by strengthening the sales structure and pursuing a VIP strategy
07Actively invest in supporting overseas sales expansion in the United States and South Korea
08Specialize medical marketing in regenerative medicine and aim to monetize it during the fiscal year ending March 2027
09Target upside through the sale of shares and other assets, in addition to stable income from corporate bond interest
Plan assumptionsNumerical assumptions for exchange rates, market growth rates, raw material prices and other factors are not disclosed. Taking into account the possibility that customer companies may refrain from carrying out marketing activities because of inventory shortages, among other factors, the earnings forecast has been conservatively reduced.
Segment targetSegment name EC consulting business / Sales Target 1,470 million yen / Operating profit target Not disclosed / Target fiscal year Earnings forecast for the fiscal year ending March 2027, Segment name Marketing Business / Sales Target 7,917 million yen / Operating profit target Not disclosed / Target fiscal year Earnings forecast for the fiscal year ending March 2027, Segment name Investment / Sales Target ¥113 million / Operating profit target Not disclosed / Target fiscal year Earnings forecast for the fiscal year ending March 2027
Non-financial targetsIndicator name Medical marketing / Target value Monetization during the fiscal year ending March 2027 / Timing During the fiscal year ending March 2027
Size of the Target MarketMarket Japan's B2C e-commerce market for merchandise / Dimensions 2024: approximately ¥15.2194 trillion / Growth rate and other metrics Approximately 2.2 times larger over 10 years; e-commerce penetration rate of 9.78% / Source Information Economy Division, Commerce and Information Policy Bureau, Ministry of Economy, Trade and Industry, "Fiscal 2024 E-Commerce Market Survey Report", Market Japan's influencer marketing market / Dimensions 2024: ¥86 billion; 2029: ¥164.5 billion / Growth rate and other metrics Not disclosed / Source CyberBuzz / Digital InFact research, Market Japan's internet advertising market / Dimensions Not disclosed / Growth rate and other metrics 50.2% of total advertising expenditure in 2025 / Source Dentsu, "Advertising Expenditures in Japan in 2025"
Risks identified by the company
Risks related to market trends in the Marketing business
Service Obsolescence Risk
Risks related to the Investment business
Risk related to impairment of goodwill
Reason for revision or withdrawal
Taking into account the possibility that customer companies may refrain from carrying out marketing activities because of inventory shortages arising from global conditions, among other factors, the earnings forecast has been conservatively reduced for net sales and gross profit.
| Item | Details |
|---|---|
| Plan name | Growth Strategy and Medium-Term Management Targets |
| Progress against the plan | Annual update |
| Sales Target | 8,278 (actual for the fiscal year ended March 2026) → 9,500 (earnings forecast for the fiscal year ending March 2027)（+14.8%） |
| Operating profit target | 727 (actual for the fiscal year ended March 2026) → 900 (earnings forecast for the fiscal year ending March 2027)（+23.8%） |
| Net income target | 216 (actual for the fiscal year ended March 2026) → 450 (earnings forecast for the fiscal year ending March 2027)（+107.6%） |
| Payout ratio / DOE policy | Numerical targets for the payout ratio and DOE are not disclosed. The basic policy is to continuously increase dividends per share. The dividend forecast for the fiscal year ending March 2027 is ¥36. The period covered is as long as medium- to long-term earnings growth and EPS growth are expected. |
| Segment target | Segment name EC consulting business / Sales Target 1,470 million yen / Operating profit target Not disclosed / Target fiscal year Earnings forecast for the fiscal year ending March 2027, Segment name Marketing Business / Sales Target 7,917 million yen / Operating profit target Not disclosed / Target fiscal year Earnings forecast for the fiscal year ending March 2027, Segment name Investment / Sales Target ¥113 million / Operating profit target Not disclosed / Target fiscal year Earnings forecast for the fiscal year ending March 2027 |
| Non-financial targets | Indicator name Medical marketing / Target value Monetization during the fiscal year ending March 2027 / Timing During the fiscal year ending March 2027 |
| Plan assumptions | Numerical assumptions for exchange rates, market growth rates, raw material prices and other factors are not disclosed. Taking into account the possibility that customer companies may refrain from carrying out marketing activities because of inventory shortages, among other factors, the earnings forecast has been conservatively reduced. |
| Key initiatives | Strengthen the operating structure through the use of AI, Strengthen sales by building a sales organization, Expand customer categories beyond beauty, Develop services integrated with e-commerce, Increase users and expand the customer base by enhancing real-world experiences and the community, Achieve continued growth by strengthening the sales structure and pursuing a VIP strategy, Actively invest in supporting overseas sales expansion in the United States and South Korea, Specialize medical marketing in regenerative medicine and aim to monetize it during the fiscal year ending March 2027, Target upside through the sale of shares and other assets, in addition to stable income from corporate bond interest |
| Results under the previous plan | Medium-Term Management Target (¥1 billion in operating profit) → Achieved ahead of schedule in the fiscal year ended March 2023 |
| Reason for revision or withdrawal | Taking into account the possibility that customer companies may refrain from carrying out marketing activities because of inventory shortages arising from global conditions, among other factors, the earnings forecast has been conservatively reduced for net sales and gross profit. |
| Size of the Target Market | Market Japan's B2C e-commerce market for merchandise / Dimensions 2024: approximately ¥15.2194 trillion / Growth rate and other metrics Approximately 2.2 times larger over 10 years; e-commerce penetration rate of 9.78% / Source Information Economy Division, Commerce and Information Policy Bureau, Ministry of Economy, Trade and Industry, "Fiscal 2024 E-Commerce Market Survey Report", Market Japan's influencer marketing market / Dimensions 2024: ¥86 billion; 2029: ¥164.5 billion / Growth rate and other metrics Not disclosed / Source CyberBuzz / Digital InFact research, Market Japan's internet advertising market / Dimensions Not disclosed / Growth rate and other metrics 50.2% of total advertising expenditure in 2025 / Source Dentsu, "Advertising Expenditures in Japan in 2025" |
| Risks identified | Risks related to market trends in the Marketing business, Service Obsolescence Risk, Risks related to the Investment business, Risk related to impairment of goodwill |
| Publication date | 30 June 2026 |
Items this document does not state (10)
Plan periodOperating profit margin targetROE targetROIC targetTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorDate of board resolution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher revenue and profit are expected due to growth in the Marketing business and a full-year contribution from the EC Consulting business. However, taking into account the possibility that customer companies may refrain from carrying out marketing activities because of inventory shortages arising from global conditions, among other factors, the earnings forecast has been conservatively reduced. The Investment business is expected to report lower revenue and profit due to a decrease in the value of investment securities held for operating purposes.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.